Page last updated: 2024-08-24

plerixafor and Animal Mammary Carcinoma

plerixafor has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Y; Chang, AE; Chen, Q; Chen, X; Dai, F; Hu, Y; Huang, S; Li, Q; Lundy, SK; Ren, X; Tao, H; Wang, Y; Xia, L; Xia, Y; Zhou, L	1

Other Studies

1 other study(ies) available for plerixafor and Animal Mammary Carcinoma

Article	Year
IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. Oncotarget, 2016, Sep-13, Volume: 7, Issue:37 Topics: Animals; B-Lymphocytes; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Cytotoxicity, Immunologic; Female; Heterocyclic Compounds; Humans; Immunity, Humoral; Immunotherapy, Adoptive; Interleukin-10; Interleukin-2; Mammary Neoplasms, Animal; Mice; Perforin; Receptors, CXCR4; Receptors, Interleukin-2	2016

Article

Year

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.

Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

Topics: Animals; B-Lymphocytes; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Cytotoxicity, Immunologic; Female; Heterocyclic Compounds; Humans; Immunity, Humoral; Immunotherapy, Adoptive; Interleukin-10; Interleukin-2; Mammary Neoplasms, Animal; Mice; Perforin; Receptors, CXCR4; Receptors, Interleukin-2

2016